Clinical Pathologist specialized for Lung Cancer, Digital strategy Advisor for Cerba Healthcare and CEO at Biokortex Company.
Evolving clinical trial models: Digitization is providing an impetus to move away from centralized (high cost and difficult to access settings) to more virtual (patient-centric and efficient) models.
Dr. Ko is a clinical pathologist and he spent 5 years in medical research at Gustave Roussy Institute after his medicine internship. He is a specialist in lung cancer and cell death phenomena. He’s now working as a medical doctor for Cerba healthcare and advises the group's digital strategy. He is the founder and CEO of Biokortex.